Teladoc Health to Announce First-Quarter Financial Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 7/26/2026
- Nasdaq lags on angst over AI spending ahead of earnings reports
- Elon Musk’s trillion-dollar meltdown: How SpaceX and Tesla erased $700 billion
- Intel jumps 10% after AI-fueled quarter crushes estimates, upbeat outlook
- Oil falls on report China pushing for end US-Iran war
- Why Meta, Microsoft, and Nvidia are championing open-weight AI
- FDA approves Tylenol with Naproxen as first OTC combo pain reliever
- AMD (AMD) PT Raised to $1,250 at Baird
- Pakistan, Iran explore path towards new talks with US in a China-initiated push, sources say
- Elon Musk’s trillion-dollar meltdown: How SpaceX and Tesla erased $700 billion
- Nasdaq lags on angst over AI spending ahead of earnings reports
Needham & Company Starts Teladoc (TDOC) at Buy
April 15, 2021 5:38 AM EDTNeedham & Company analyst Ryan MacDonald initiates coverage on Teladoc (NYSE: TDOC) with a Buy rating and a price target of $235.00.
The analyst comments "While Teladoc's market-leading position placed the company in a prime position to benefit from the pandemic-driven surge in adoption of... More
